Ilyang Pharmaceutical Co Ltd (007575) — Financial Flexibility Index
Ilyang Pharmaceutical Co Ltd (007575) has a Financial Flexibility Index of 0.03x as of June 2025. Free cash flow of ₩5.58 Billion (operating CF ₩2.26 Billion minus capex ₩3.32 Billion) represents 0% of total liabilities (₩205.41 Billion). Check 007575 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ilyang Pharmaceutical Co Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Ilyang Pharmaceutical Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Ilyang Pharmaceutical Co Ltd generate cash.
Annual Financial Flexibility Index for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Ilyang Pharmaceutical Co Ltd. Explore 007575 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | ₩46.24 Billion | ₩5.61 Billion | ₩189.63 Billion | ▲ +82.1% |
| 2023 | 0.13x | ₩21.45 Billion | ₩14.62 Billion | ₩160.25 Billion | ▼ -18.8% |
| 2022 | 0.16x | ₩34.02 Billion | ₩29.94 Billion | ₩206.33 Billion | ▼ -54.1% |
| 2021 | 0.36x | ₩79.93 Billion | ₩67.02 Billion | ₩222.51 Billion | ▲ +3.1% |
| 2020 | 0.35x | ₩67.66 Billion | ₩57.48 Billion | ₩194.19 Billion | ▲ +95.0% |
| 2019 | 0.18x | ₩38.37 Billion | ₩36.19 Billion | ₩214.72 Billion | ▲ +67.9% |
| 2018 | 0.11x | ₩23.67 Billion | ₩22.12 Billion | ₩222.37 Billion | ▼ -29.0% |
| 2017 | 0.15x | ₩33.81 Billion | ₩30.03 Billion | ₩225.39 Billion | ▼ -14.0% |
| 2016 | 0.17x | ₩37.29 Billion | ₩26.98 Billion | ₩213.91 Billion | ▼ -31.7% |
| 2015 | 0.26x | ₩56.35 Billion | ₩40.27 Billion | ₩220.62 Billion | ▲ +94.3% |
| 2014 | 0.13x | ₩32.51 Billion | ₩18.63 Billion | ₩247.37 Billion | — |